BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35151889)

  • 1. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT.
    Fukuhara H; Yamamoto S; Lai HW; Karashima T; Kurabayashi A; Furihata M; Inoue K
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102757. PubMed ID: 35151889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
    Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan.
    Fukuhara H; Hagiwara Y; Oba K; Inoue K
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103758. PubMed ID: 37604217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
    Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H
    Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Real-life experience': recurrence rate at 3 years with Hexvix
    Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P
    World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
    Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].
    Sugino Y; Nishikawa K; Kato M; Sasaki T; Kato M; Masui S; Yoshio Y; Kanda H; Sugimura Y; Inoue T
    Hinyokika Kiyo; 2021 Jul; 67(7):303-308. PubMed ID: 34353010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
    Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K
    Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
    Nakagawa R; Nohara T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103574. PubMed ID: 37080348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.
    Miyake M; Nishimura N; Nakai Y; Fujii T; Owari T; Hori S; Morizawa Y; Gotoh D; Anai S; Torimoto K; Tanaka N; Hirao Y; Fujimoto K
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer.
    Heer R; Lewis R; Vadiveloo T; Yu G; Mariappan P; Cresswell J; McGrath J; Nabi G; Mostafid H; Lazarowicz H; Kelly J; Duncan A; Penegar S; Breckons M; Wilson L; Clark E; Feber A; Orozco-Leal G; Tandogdu Z; Taylor E; N'Dow J; Norrie J; Ramsay C; Rice S; Vale L; MacLennan G; Hall E
    NEJM Evid; 2022 Oct; 1(10):EVIDoa2200092. PubMed ID: 38319866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
    Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2024 Apr; ():. PubMed ID: 38687165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
    Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H
    Int J Urol; 2024 May; ():. PubMed ID: 38695571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study.
    Arai T; Sazuka T; Oka R; Tsukamoto R; Sato H; Goto Y; Imamura Y; Sakamoto S; Ichikawa T
    Anticancer Res; 2023 Aug; 43(8):3615-3621. PubMed ID: 37500129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
    Watanabe K; Tamura K; Matsushita Y; Watanabe H; Motoyama D; Ito T; Sugiyama T; Otsuka A; Miyake H
    Cancer Diagn Progn; 2021; 1(3):201-205. PubMed ID: 35399308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in photodynamic diagnosis for bladder cancer due to the quality of endoscopic equipment.
    Nohara T; Kamijima T; Fukuda R; Kano H; Shimada T; Nakano T; Kato Y; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102628. PubMed ID: 34808397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety.
    Yamamoto S; Fukuhara H; Karashima T; Inoue K
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101999. PubMed ID: 32920180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive bladder cancer: A comparative study from experienced institutes.
    Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    BJUI Compass; 2023 May; 4(3):305-313. PubMed ID: 37025476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.